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Alveolar hydatid disease (AHD) in humans is caused by
infection with the proliferative larval stage of the small fox
tapeworm  Echinococcus multilocularis. Once the infection
becomes successfully established, AHD is one of the most
lethal helminthic diseases in humans (1). Infection sources,
risk, and rates for humans may be related to prevalence in
wild and domestic animals. In a recent study, we described
highly endemic E. multilocularis in a small area of the canton
of Fribourg, Switzerland (2). An E. multilocularis prevalence
of 47% to 56% per year was found in the fox population.
Prevalence in the local Arvicola terrestris population
fluctuated annually between 11% and 39%. The wide
distribution of E. multilocularis eggs in the study area,
reflected by the high prevalence in rodents, may have
represented a considerable risk for humans in the densely
populated periurban regions of Switzerland. Recently,  high
E. multilocularis prevalence was also found in urban fox and
rodent populations, which may represent an even higher
infection risk for humans (3). However, in spite of high
prevalence in the definitive host in most parts of Switzerland
(north of the Alps), disease in humans is relatively rare. In
recent decades, the annual death rate for AHD in
Switzerland has been 0.18 cases per 100,000 inhabitants
(4). Another study in the United States found no association
between high prevalence of E. multilocularis in wild canids
and deaths in trappers from South Dakota (5). A link between
prevalence in natural definitive and intermediate wildlife
hosts and domestic definitive hosts with infection risk and
prevalence of disease in humans has not been examined in
Switzerland.
On the basis of our previous findings (2,6,7), we designed
the present study to determine the effect of a naturally
occurring persistent high prevalence in wildlife hosts on
domestic animals (dogs and cats) and assess (by serologic and
clinical tests) the exposure rate of humans living in the area.
Methods
The study was carried out from 1993 to 1998 in a
periurban  area north of the city of Fribourg. The primary (or
rodent) study site has been described (2,7). A secondary area
for studying the E. multilocularis infection rate in cats and
dogs was delineated by an approximate 5-km radius around
the primary site. A tertiary area for studying seroprevalence
in human blood donors included approximately 20% of the
surface area of the canton of Fribourg (representing
approximately 400 km2 surrounding the primary site).
Survey in Intermediate Hosts (Rodents)
The rodent survey has been ongoing since spring 1993.
The study period assessed in this article is spring 1993 to
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spring 1998. A. terrestris and Microtus arvalis were caught as
described (7) by using standardized 100-m trap lines to obtain
density estimates (8). Each trapped animal was assessed for
biologic variables and E. multilocularis infection status as
described (2,7). Liver parts were preserved in 70% ethanol
and 4% buffered paraformaldehyde after microscopy
examination to detect metacestode lesions. All preserved
lesions were subsequently assessed by immunohistochemis-
try or polymerase chain reaction (PCR) (2).
Survey in Definitive Hosts (Dogs and Cats)
Three local veterinarians participated in the survey by
distributing information and diagnostic fecal containers to
dog and cat owners. This part of the study took place from
June 1996 to October 1997. Fecal samples were examined by
the following methods: Taeniid egg detection by microscopy
following a flotation enrichment (9); identification of isolated
E. multilocularis eggs by PCR (10); and detection of
E. multilocularis antigens by sandwich-enzyme-linked
immunosorbent assay (ELISA) (9). Owners of E. multilocu-
laris-positive dogs or cats obtained detailed information and
support by their veterinarians for treating E. multilocularis-
infected animals and taking the necessary safety precautions,
which included a recommendation to inform their physicians
about previous exposure risk and to have all household
members undergo serologic testing (procedures described in
the next section).
Survey in Humans
The seroepidemiologic survey was done in collaboration
with the Blood Transfusion Centre, Cantonal Hospital,
Fribourg. Serum samples were obtained from 2,943 blood
donors in October 1996 to August 1997. The blood donation
collection area included 38 villages located in the periphery of
the initial rodent study area. In Switzerland, blood donation
is voluntary and not compensated financially. Blood donation
statistics have shown that a constant rate of 15% of the
population (independent of geographic area) participates in
blood donation (men four times and women three times a
year). The sampling strategy was designed by the blood
donation center to obtain all registered donors of the study
area and avoid double donations by the same person. An
identical sampling procedure and strategy had been used
earlier, which also had covered approximately 15% of the
study area (6). Informed consent was obtained from blood
donors. All sera were stored at -30°C until tested. Em2-ELISA
was performed as described, including the respective data
management processing (2,6). For complementary serologic
investigations, the serum samples were also tested in parallel
for reactivity with an E. granulosus hydatid fluid antigen
(EgHF) ELISA (11). If Em2-serologic test results were
positive, a second blood sample was obtained through the
responsible physician to rule out errors in handling the first
sample and confirm the first serologic test result. If the result
was confirmed, hepatic ultrasonography was performed in a
regional imaging center. In cases where sonography showed
hepatic lesions, the patient was referred to the University
Hospital in Bern for further assessment by computed
tomography (CT).
Statistical Analyses
Comparative statistical analyses of the present
seroepidemiologic data and those of a previous study (6) were
done with SAS v.6.12 and Fisher’s exact test (2-tail); p values
were <0.005, unless otherwise stated.
 Results
E. multilocularis were repeatedly found in intermediate
hosts (rodents). A. terrestris and M. arvalis were captured in
the same period from 1993 to 1998. The presence of
E. multilocularis metacestodes in the liver was determined by
microscopy and, if required, was confirmed by immunohis-
tochemistry and PCR. Prevalence data (Table 1) indicate that
during the study period, the area maintained a relatively
constant high infection rate (prevalence 9% to 39% for
A. terrestris and 10% to 23% for M. arvalis). The yearly
fluctuation of prevalence of A. terrestris was different from
that of M. arvalis. For A. terrestris, a significant interannual
temporal effect (p <0.005) was observed. No significant
interannual effect was observed for M. arvalis.
E. multilocularis in Definitive Hosts (Dogs and Cats)
The prevalence of intestinal E. multilocularis infection in
dogs and cats living near the area under investigation is
provided in Table 2. The definitive prevalence of 7% for dogs
and 3% for cats may be underestimated as the veterinarians
involved in the collection of samples informed regional cat and
dog owners about the possibility of preventing infection by
monthly administration of praziquantel (5 mg per kg body
weight). Bias was suggested by the fact that most
E. multilocularis-positive dogs were detected at the beginning
of this study in 1996.
Table 1. Prevalence of Echinococcus multilocularis in Arvicola terrestris and Microtus arvalis captured in spring 1993 and 1998
   No. of               No. positive by   No. of                No. positive by
A. terrestris     microscopy/immunochemistrya M. arvalis microscopy/immunohistochemistry
Year   trapped PCRb (%) [95% CI]  trapped PCR (%) [95% CI]
1993   28 11 (39) [21-57]   nt  --   –     --
1994   44   5 (11) [  2-20]   20   2 (10) [  3-23]
1995   67   6 (  9) [  2-16]   61 13 (21) [11-32]
1996   49 10 (20) [  9-21]   55   9 (16) [  7-26]
1997   59   4 (  7) [  1-13]   52 12 (23) [12-35]
1998   46   4 (  9) [  1-17]   32   5 (16)   [3-28]
Totals 293 40 (14) [  1-18] 220 41 (19) [13-24]
aPositivity is based on a primary microscopy lesion detection and subsequent confirmation of E. multilocularis by immunohistochemistry and
PCR.
bPCR, polymerase chain reaction; nt, not trapped.410 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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E. multilocularis in Humans
Sera from 2,943 healthy blood donors were tested by
Em2-ELISA (Table 3). All six Em2-positive blood donors had
a relatively high anti-Em2 antibody concentration (>15
antibody units, AU) (11). The donors were referred to their
physicians for hepatic imaging analyses by ultrasonography.
Four of the six donors agreed to this procedure; in three of the
four, no lesions could be detected by the initial
ultrasonography. The procedure was repeated approximately
6 months and 24 months after immunodiagnosis and then
annually. No lesions have been detected in these three donors;
one, however, had a small echodense lesion of a few
centimeters in diameter in the right liver lobe (Figure, A). The
donor was referred to the outpatient clinic of the University
Hospital in Bern for an abdominal CT, which confirmed the
presence of a small hypodense lesion assumed to be fully
calcified (Figure, B). No other pathologic changes of the liver
were observed. As the morphologic features of this lesion
matched the criteria for nonviable, so-called “died-out” or
“abortive” lesions (1,12,13), the case was classified in this
category. Further CT investigations using contrast enhance-
ment detected a very small hypodense area in the periphery of
the calcified herd, which could have harbored a putatively
still viable parasitic zone (Figure, C). The patient was
reexamined by CT at the same time intervals as described
above for the other seropositive donors. No changes in size and
morphologic features of the calcified lesion and the peripheral
hypodense zone have been demonstrated. The patient
received no treatment at any time. The inert lesion was
definitively rated as abortive in 1999.
In parallel, all sera were serologically tested by EgHF-
ELISA  to compare data with those from a former study
performed in Switzerland in 1985-86 (2). Of 2,943 sera, 33
were seropositive in this EgHF ELISA (including the six Em2-
positive sera described above). Ten EgHF ELISA-positive (but
Em2-negative) persons were arbitrarily selected for a
subsequent hepatic ultrasonography investigation. Nine
persons had negative ultrasonography results. One person,
however, had a typical hepatic E. granulosus hydatid cyst of 5
cm in diameter and was referred to his physician for further
clinical testing and treatment.
Table 2. Prevalence of Echinococcus multilocularis in dogs and cats, 1996a
    Final
No. posi-   E. multi-
 No. of  tive for No. posi- No. posi-   locularis
animals  taeniid   tive by   tive by    positive
Animal  tested    eggs     PCR   ELISA diagnosis (%)
Feral dogs 86 7b 6bc 6bc 6/86 (7)
Cats 33 1 1 1 1/33 (3)
aPolymerase chain reaction (PCR) was performed directly on eggs following a
taeniid egg isolation (9).
bOne dog had a borderline coproantigen reactivity. Subsequent investigations
provided a negative Echinococcus-PCR by the presence of taeniid eggs. Thus,
final test interpretation did not indicate E. multilocularis infection.
cPCR- and copro-Ag-positivity refers to all the same animals. The one dog
exhibiting a borderline copro-Ag-reactivity is not in these group of animals.
Table 3. Specific seroprevalences for Echinococcus multilocularis in
blood donorsa
  No. (%)  [95%-CI]
Blood donors tested (total) 2,943
Em2-positive blood donorsb       6b (0.2) [0.04-0.36]
EgHF-positive blood donors      33c (1.1)   [0.5-2.1]
  but negative by Em2
aAssessed primarily by Em2-enzyme-linked immunosorbent assay (ELISA),
complementary serologic data were obtained with the E. granulosus hydatid
fluid antigen-ELISA. Blood samples were collected from October 1996 to July
1997.
bFour of six Em2-positive blood donors received imaging investigations, one of
which was computed tomography-positive for an alveolar hydatid disease
(AHD) lesion. Two Em2-positive donors refused subsequent imaging
investigations but have had no signs of AHD.
cTen donors with high E. granulosus hydatid fluid antigen-titers but negative
in Em2-ELISA were selected for pilot imaging investigations. One had a cystic
hepatic lesion of 2.5 cm in diameter. Morphologic features were compatible
with those of E. granulosus cysts.
Figure. Abortive alveolar echinococcosis detected in a 44-year-old blood
donor in Switzerland. A, ultrasonography of the liver demonstrates the
presence of a small echodense lesion (arrow). B, a liver computed
tomography scan shows a small, hypodense, apparently fully calcified
lesion (arrow). C, after contrast enhancement, a very small hypodense
area in the periphery of the calcified herd was detected (arrow).Vol. 7, No. 3, May–June 2001 Emerging Infectious Diseases 411
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Retrospective Statistical Comparative Analyses
Seroprevalence and clinical findings obtained in the
present study (Table 3) were directly compared with those
obtained in a previous study, which had used similar
immunodiagnostic tools and  blood donor population (6). The
key data used from this previous study originated from 17,166
blood donors, six Em2-ELISA-positive  (two of these with
hepatic lesions by CT). Subsequent surgery confirmed the
presence of active E. multilocularis metacestodes. Of 5,166
blood donors additionally tested with EgHF-ELISA, 16 Em2-
ELISA-negative donors had EgHF seropositivity. Echinococ-
cosis tests and standard laboratory tools were the same in
both studies (11): Diagnostic sensitivity of the Em2-ELISA
was 95%, and specificity was 100%. Diagnostic sensitivity of
the EgHF-ELISA was 96%, and specificity was 97%. By these
key data and the 2-tailed Fisher’s exact test, a significant
increase of  seroprevalence from 1986 to 1996-97 became
apparent for both the Em2-ELISA (p <0.005) and the EgHF-
ELISA (p <0.01). Conversely, clinical findings (CT hepatic
lesions compatible with E. multilocularis infection) were not
significantly different between the two studies (p = 0.378).
Conclusion
Recent findings have clearly documented a persistently
high prevalence of E. multilocularis in rural and urban fox
populations of Switzerland (3,9,11,14). These data contrasted
to a persistently low annual incidence of AHD (8 to 10 new
cases per year) in accidentally infected humans (6,15,16).
Until 1996, little information was available about the
prevalence of E. multilocularis in the intermediate rodent
host. In 1996 (2), we reported a focus of high E. multilocularis
prevalence not only in foxes (annual mean 51%) but also in
rodents (annual mean 25%). The latter represented the
highest prevalence ever reported for rodents in central
Europe. The discovery and documentation of an area highly
endemic for E. multilocularis in definitive and intermediate
hosts raised the following question: Does high endemicity
have implications for the rate of infection in domestic animals
living near E. multilocularis-endemic areas and for human
health? To address this question, we first had to demonstrate
persistence of high endemicity in the rodent population. A
6-year follow-up showed that—independent of interannual
fluctuations significant for A. terrestris but not for
M. arvalis—both species remained infected at an exceptional-
ly high level. Consequently, the local dog and cat populations
hunting rodents were at a persistently high infection risk.
This risk may result in a relatively high exposure risk for
human populations in the vicinity. The number of dogs and
cats in Switzerland is relatively high (approximately 500,000
dogs and 1.2 million cats). Local veterinarians assessed the
dog and cat populations of our study area as within the Swiss
average (1 dog per 10 inhabitants and 1 cat per 5 inhabitants).
Therefore, any person in our study area may have had direct
contact with pet dogs or cats or may have been to locations
contaminated by their feces. The veterinarians confirmed
that dog and cat owners in the study area did not exhibit any
peculiarities in comparison to owners in other areas of
Switzerland, including the area and period covered by an
earlier study (6). As a precaution, all pet owners visiting
veterinary practices in the study area were given information
on E. multilocularis. The information indicated that carnivores
eating rodents in this specific area could be prophylactically
treated every 28 days with a therapeutic dose (5 mg per kg
body weight) of praziquantel. Assessment of the effectiveness
of this therapeutic regimen will be the topic of a separate study.
When we compared our study to other European studies
(17,18), we confirmed (as a consequence of the persistently
high prevalence in intermediate rodent hosts) an exceptional-
ly high prevalence of intestinal E. multilocularis infections,
especially in dogs. High prevalence among foxes, dogs, cats,
and rodents reflects high environmental contamination with
E. multilocularis eggs, putatively brought into the households
by dogs and cats. Thus, we examined the extended exposure
risk of the local human population for increases in
seroprevalence, by comparing current data with those
collected in an earlier study (6). As expected, Em2-ELISA
exhibited a significantly higher seroprevalence. (Higher
seroprevalence obtained with the EgHF-ELISA will not be
further discussed because the lower specificity of the test may
be due to other nonspecific parameters.) However, the number
of reported clinical cases did not increase. This lack of
increase in cases was underlined by the unique detection of
one abortive (died-out) case of AHD (first such case
documented in Switzerland). Earlier, we had postulated that
the time between infection and  clinical manifestation was 5
to 15 years (4,6). However, we know that, in experimental
infections of rodents, seroconversion to the Em2-antigen
occurs as early as 4 to 6 weeks after peroral inoculation of E.
multilocularis eggs (unpub. data). As our study covered a 4- to
5-year period of high endemicity (1993 to 1996-97) until the
human population was assessed, a significant increase in
clinical cases, including asymptomatic (early) cases, which
are detectable by ultrasonography, should have been
observed in our study. However, high prevalence of
E. multilocularis in wild (and domestic animals) seemed not
to be associated with a higher prevalence of AHD in humans
living in the same region.
Epidemiologic data similar to ours have recently been
reported with regard to a rural community in southwestern
Germany where a high prevalence of E. multilocularis (75%)
had been observed in foxes (13). Screening of the human
population (2,560 participants) found one case of active AHD
and nine cases of seropositivity to specific antibodies without
detectable liver lesions.
The human population in our study area exhibited low
susceptibility to AHD: The relatively high seroprevalence
observed in the population was associated with the
documented high exposure rate, but the disease rate did not
increase. (Disease cases included early cases putatively
detectable by ultrasonography.) In addition to low
susceptibility, the persistently low incidence of AHD in our
study area may also be accounted for by increased immunity,
which may protect a large proportion of infected persons. For
more detailed and definitive conclusions on disease incidence
in humans, we will  continue to monitor the affected
population. A long-term assessment of the same human
population is already planned in the Fribourg area over the
next 4 to 10 years. By using the same tools as described in this
project, it will be possible to document more subtle changes in
disease prevalence in humans.412 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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